Inspire Medical Systems (Inspire Medical Systems) Net Cash per Share : $12.05 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Inspire Medical Systems Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Inspire Medical Systems's Net Cash per Share for the quarter that ended in Dec. 2023 was $12.05.

The historical rank and industry rank for Inspire Medical Systems's Net Cash per Share or its related term are showing as below:

INSP' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 6.5 Med: 17.99 Max: 42.52
Current: 19.71

During the past 9 years, the highest Price-to-Net-Cash Ratio of Inspire Medical Systems was 42.52. The lowest was 6.50. And the median was 17.99.

INSP's Price-to-Net-Cash is ranked worse than
74.14% of 348 companies
in the Medical Devices & Instruments industry
Industry Median: 7.16 vs INSP: 19.71

Inspire Medical Systems Net Cash per Share Historical Data

The historical data trend for Inspire Medical Systems's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspire Medical Systems Net Cash per Share Chart

Inspire Medical Systems Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Cash per Share

Get a 7-Day Free Trial

4.48

6.76

5.41

13.19

12.05

Inspire Medical Systems Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Cash per Share	Get a 7-Day Free Trial															13.19	13.20	12.90	12.55	12.05

Competitive Comparison of Inspire Medical Systems's Net Cash per Share

For the Medical Devices subindustry, Inspire Medical Systems's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inspire Medical Systems's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Inspire Medical Systems's Price-to-Net-Cash falls into.

Inspire Medical Systems Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Inspire Medical Systems's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

	Net Cash per Share (A: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(460.375	-	104.297	-	0)	/	29.5605
=	12.05

Inspire Medical Systems's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

	Net Cash per Share (Q: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(460.375	-	104.297	-	0)	/	29.5605
=	12.05

Inspire Medical Systems (NYSE:INSP) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

Inspire Medical Systems Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Inspire Medical Systems's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Inspire Medical Systems (Inspire Medical Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (NYSE:INSP) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

2DR:Germany 2DR:Germany

Address

5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416

Website

https://www.inspiresleep.com

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Executives

Timothy P. Herbert	director, 10 percent owner, officer: CEO and President	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Jerry C Griffin	director	887L INDUSTRIAL ROAD, SAN CARLOS CA 94070
Carlton Weatherby	officer: Chief Strategy Officer	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Steven Jandrich	officer: Chief Comp Off & VP, Human Res	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Philip Ebeling	officer: Chief Operating Officer	INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY MN 55416
John Rondoni	officer: Chief Technology Officer	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Richard Buchholz	officer: Chief Financial Officer	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Randy Ban	officer: Senior VP. & Sales & Marketing	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Marilyn C Nelson	director	C/O EXXON MOBIL CORP, 5959 LAS COLINAS BLVD., IRVING TX 75039-2298
Cynthia Burks	director	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Charisse Y Sparks	director	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Georgia Melenikiotou	director	C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BOULEVARD, SUITE 1600, GOLDEN VALLEY MN 55416
Bryan K Phillips	officer: See Remarks	9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Shelley G. Broader	director	880 CARILLON PARKWAY, ST. PETERSBURG FL 33702
Casey M Tansey	director, 10 percent owner	2735 SAND HILL ROAD, MENLO PARK CA 94025